Continuous Glucose Monitoring during Exercise in Patients with Type 1 Diabetes on Continuous Subcutaneous Insulin Infusion

Por Kapitza, Christoph, Hövelmann, Ulrike, Nosek, Leszek, Kurth, Heinz-Joerg, Essenpreis, Matthias, Heinemann, Lutz
Publicado em 2010

A Comparison of Pharmacokinetic and Pharmacodynamic Properties Between Faster-Acting Insulin Aspart and Insulin Aspart in Elderly Subjects with Type 1 Diabetes Mellitus

Por Heise, Tim, Hövelmann, Ulrike, Zijlstra, Eric, Stender-Petersen, Kirstine, Jacobsen, Jacob Bonde, Haahr, Hanne
Publicado no Drugs Aging (2016)

Pharmacokinetic Properties of Fast-Acting Insulin Aspart Administered in Different Subcutaneous Injection Regions

Por Hövelmann, Ulrike, Heise, Tim, Nosek, Leszek, Sassenfeld, Bettina, Thomsen, Karen Margrete Due, Haahr, Hanne
Publicado no Clin Drug Investig (2017)

Biphasic Insulin Aspart 30/70: Pharmacokinetics and Pharmacodynamics Compared With Once-Daily Biphasic Human Insulin and Basal-Bolus Therapy

Por Heise, Tim, Heinemann, Lutz, Hövelmann, Ulrike, Brauns, Bianca, Nosek, Leszek, Haahr, Hanne L., Olsen, Klaus J.
Publicado em 2009

Pharmacokinetic and Pharmacodynamic Properties of Faster-Acting Insulin Aspart versus Insulin Aspart Across a Clinically Relevant Dose Range in Subjects with Type 1 Diabetes Mellit...

Por Heise, Tim, Stender-Petersen, Kirstine, Hövelmann, Ulrike, Jacobsen, Jacob Bonde, Nosek, Leszek, Zijlstra, Eric, Haahr, Hanne
Publicado no Clin Pharmacokinet (2016)